WHO publishes a document summarizing evidence gaps articulated in various WHO TB policy guidance to help steer innovation towards sustainable public health interventions required to end TB.

TB Europe Coalition releases a guide explaining the whole data collection process for four new indicators of the WHO Regional Office for Europe regarding the meaningful involvement of civil society in TB response.

Sign up for a Call to Action for accelerating the implementation of shorter and more effective treatment for all people with drug-resistant TB.

The Global TB CAB and TAG commend the investigators for sharing results early and openly with a diverse group of key stakeholders, and urge the scientific community and funders to continue efforts to find different options to prevent TB.

Vaccine well tolerated and demonstrated immunogenicity but did not provide protection against TB recurrence; Participants being informed; Further analysis continues.

A viewpoint, published in Public Health Action, advocates for transparent, accessible pre-approval access as a core element of person-centered care for drug-resistant TB.

The Scorecard aims to enhance visibility and multisectoral accountability regarding legal, policy and human rights barriers experienced by people affected by TB.

The Stop TB Partnership releases the estimated country shares of global targets committed in the Political declaration of the UN High-Level Meeting on TB, held in September 2023.

TB research and development funding perilously off track of UN commitments to end TB by 2030.

Treatment Action Group launches the 2023 Tuberculosis Diagnostics Pipeline Report.